Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Prior Omicron infection protects against BA.4 and BA.5 variants

A man is tested at a COVID-19 testing van as persons wait in line in New York City, U.S. on June 06, 2022.

People queue at a COVID-19 test site in New York City last month, when the BA.4 and BA.5 subvariants were taking hold.Credit: John Smith/VIEWpress/Getty

The Omicron BA.4 and BA.5 subvariants of SARS-CoV-2 have proven to be stealthier at evading people’s immune defences than all of their predecessors.

But recent research shows that previous infection with an older variant (such as Alpha, Beta or Delta) offers some protection against reinfection with BA.4 or BA.5, and that a prior Omicron infection is substantially more effective. That was the conclusion of a study that evaluated all of Qatar’s COVID-19 cases since the wave of BA.4 and BA.5 infections began1.

The work, which was posted on the medRxiv preprint server on 12 July and has not yet been peer reviewed, feeds into broader research on “how different immunities combine with each other”, says study co-author Laith Abu-Raddad, an infectious-disease epidemiologist at Weill Cornell Medicine-Qatar in Doha.

Everyone has a different immune history, because people have received different combinations of COVID-19 vaccines and been infected with assorted variants during the course of the pandemic. “Different histories equip people with different immunity against upcoming infection,” says Abu-Raddad. Knowing how these diverse immune responses interact inside a person will be “very important for the future of the pandemic”, he adds.

Natural immunity

To see how much protection previous infection offers against the two Omicron subvariants, Abu-Raddad and colleagues analysed COVID-19 cases recorded in Qatar between 7 May this year — when BA.4 and BA.5 first entered the country — and 4 July. They looked at the number of people known to have been infected previously who tested positive or negative for COVID-19, and identified which infections were caused by BA.4 or BA.5 by examining positive test samples to see whether they contained a specific gene mutation.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-022-01950-2

Updates & Corrections

  • Correction 25 July 2022: An earlier version of this article said that researchers identified which infections were caused by BA.4 or BA.5 by searching for a protein that the subvariants lack. In fact, the protein is still present in BA.4 and BA.5 but contains a mutation.

References

  1. Altarawneh, H. N. et al. Preprint at medRxiv https://doi.org/10.1101/2022.07.11.22277448 (2022).

  2. Chemaitelly, H. et al. Preprint at medRxiv https://doi.org/10.1101/2022.07.06.22277306 (2022).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links